Replies to post #102689 on Biotech Values

[DewDiligence]

FDA approves NVS’ triple-MoA hypertension pill consisting of Tekturna + Norvasc + HCTZ:

http://finance.yahoo.com/news/Novartis-Gains-FDA-Approval-prnews-28317699.html?x=0&.v=1

The brand name of the 3-in-1 pill is Amturnide (which contains a fragment of each of the three drug names).

NVS already sells a 2-in-1 pill consisting of Tekturna + Norvasc under the brand name, Tekamlo (#msg-53782319).